Desjardins Global Asset Management »

Jazz Pharmaceuticals shares owned by Desjardins Global Asset Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Desjardins Global Asset Management from 13F filings

Historical chart of Desjardins Global Asset Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Desjardins Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Desjardins Global Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.9M 16k 123.00

More positions owned by Desjardins Global Asset Management

Vaneck Vectors Gold Miners Etf Exchange Traded Fund Share (GDX)
Microsoft Corp Common Stock (MSFT)
Ishares Russell 2000 Exchange Traded Fund Share (IWM)
Ishares Core S&p 500 Etf Exchange Traded Fund Share (IVV)
Apple Common Stock (AAPL)
Ishares Msci Emerging Markets Ex China Etf Exchange Traded Fund Share (EMXC)
Cintas Corp Common Stock (CTAS)
Nvidia Corp Common Stock (NVDA)
Zoetis Common Stock (ZTS)
Amazon.com Common Stock (AMZN)
Meta Platforms Common Stock (META)
Booking Holdings Common Stock (BKNG)
Ishares Esg Aware Msci Eafe Etf Exchange Traded Fund Share (ESGD)
Invesco Qqq Trust Series 1 Exchange Traded Fund Share (QQQ)
Alphabet Inc A Common Stock (GOOGL)

View all positions for Desjardins Global Asset Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Capital World Investors
Dimensional Fund Advisors
LSV Asset Management
Jpmorgan Chase & Co
State Street Corporation
Franklin Resources
EcoR1 Capital
Hanna Zanoni
Ameriprise Financial
Geode Capital Management
Bank of New York Mellon
GoldenTree Asset Management
Swedbank AB

View all funds holding Jazz Pharmaceuticals